Stockscreener 앱 받기
177.85
0.56%
-1.01
시간 외 거래:
177.85
전일 마감가:
$178.86
열려 있는:
$176.04
하루 거래량:
1.16M
Relative Volume:
1.20
시가총액:
$8.75B
수익:
$4.06B
순이익/손실:
$413.08M
주가수익비율:
22.20
EPS:
8.01
순현금흐름:
$560.48M
1주 성능:
-5.36%
1개월 성능:
+0.29%
6개월 성능:
+50.14%
1년 성능:
-2.54%
1일 변동 폭
$175.83
$180.19
1주일 범위
$173.89
$191.41
52주 변동 폭
$91.86
$230.02
Charles River Laboratories International Inc Stock (CRL) Company Profile
명칭
Charles River Laboratories International Inc
전화
781-222-6000
주소
251 BALLARDVALE ST, WILMINGTON, MA
CRL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CRL
Charles River Laboratories International Inc
|
177.85 | 8.80B | 4.06B | 413.08M | 560.48M | 8.01 |
|
TMO
Thermo Fisher Scientific Inc
|
565.24 | 212.23B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
213.83 | 151.20B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
722.12 | 57.84B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
146.08 | 41.02B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
210.96 | 36.42B | 15.90B | 1.28B | 2.21B | 7.2842 |
Charles River Laboratories International Inc Stock (CRL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-06 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2025-10-02 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2025-09-09 | 업그레이드 | Jefferies | Hold → Buy |
| 2025-07-09 | 업그레이드 | Citigroup | Neutral → Buy |
| 2025-05-23 | 업그레이드 | Redburn Atlantic | Neutral → Buy |
| 2025-05-14 | 업그레이드 | TD Cowen | Hold → Buy |
| 2025-05-08 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2025-03-21 | 다운그레이드 | Goldman | Buy → Neutral |
| 2025-03-04 | 업그레이드 | Citigroup | Sell → Neutral |
| 2025-03-03 | 업그레이드 | Redburn Atlantic | Sell → Neutral |
| 2025-01-22 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2025-01-17 | 다운그레이드 | UBS | Buy → Neutral |
| 2024-11-18 | 다운그레이드 | CLSA | Hold → Underperform |
| 2024-11-07 | 업그레이드 | CLSA | Underperform → Hold |
| 2024-10-23 | 개시 | CLSA | Underperform |
| 2024-10-14 | 개시 | Redburn Atlantic | Sell |
| 2024-10-07 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2024-10-02 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2024-10-01 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2024-08-08 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-08-08 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-06-28 | 다운그레이드 | Argus | Buy → Hold |
| 2024-06-07 | 개시 | Mizuho | Neutral |
| 2024-06-06 | 개시 | Goldman | Buy |
| 2024-02-15 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2023-09-13 | 개시 | TD Cowen | Market Perform |
| 2023-07-10 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2023-02-23 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2023-01-12 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-09-30 | 업그레이드 | Jefferies | Hold → Buy |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2022-08-04 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-05-24 | 개시 | Guggenheim | Neutral |
| 2022-04-25 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-04-07 | 개시 | Stephens | Overweight |
| 2022-02-17 | 재확인 | BofA Securities | Buy |
| 2022-02-17 | 업그레이드 | Citigroup | Neutral → Buy |
| 2022-02-17 | 재확인 | Deutsche Bank | Buy |
| 2022-02-17 | 재확인 | Morgan Stanley | Overweight |
| 2022-02-17 | 재확인 | UBS | Buy |
| 2021-08-05 | 재개 | Credit Suisse | Neutral |
| 2020-12-16 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2020-09-10 | 업그레이드 | Jefferies | Hold → Buy |
| 2020-07-01 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-05-13 | 업그레이드 | UBS | Neutral → Buy |
| 2020-04-21 | 다운그레이드 | Jefferies | Buy → Hold |
| 2020-03-27 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-03-02 | 개시 | Deutsche Bank | Buy |
| 2020-02-18 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2020-01-10 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-01-08 | 개시 | Wells Fargo | Overweight |
| 2020-01-07 | 개시 | Citigroup | Buy |
| 2019-10-18 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2019-06-10 | 개시 | SVB Leerink | Outperform |
| 2019-04-30 | 재개 | Evercore ISI | Outperform |
| 2018-12-14 | 개시 | Deutsche Bank | Buy |
| 2018-10-09 | 개시 | UBS | Neutral |
| 2018-08-23 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2018-07-17 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2018-06-15 | 업그레이드 | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2018-02-14 | 업그레이드 | SunTrust | Hold → Buy |
모두보기
Charles River Laboratories International Inc 주식(CRL)의 최신 뉴스
Charles River Laboratories Q3 2025 Earnings Preview - MSN
Assetmark Inc. Purchases 18,557 Shares of Charles River Laboratories International, Inc. $CRL - MarketBeat
Will Charles River Laboratories' (CRL) ADC Partnership Redefine Its Edge in Biotech Collaboration? - simplywall.st
Using RSI to spot recovery in Charles River Laboratories International Inc.Weekly Trend Summary & Safe Capital Investment Plans - newser.com
Is Charles River Laboratories International Inc. stock vulnerable to rate hikesTrend Reversal & Precise Buy Zone Identification - newser.com
Will Charles River Laboratories International Inc. stock maintain dividend yield2025 Year in Review & Real-Time Buy Zone Alerts - newser.com
Can Charles River Laboratories International Inc. stock deliver double digit returnsJuly 2025 PreEarnings & AI Enhanced Trade Execution Alerts - newser.com
Does Charles River Laboratories International Inc. (RV6) stock trade below intrinsic valueJuly 2025 Sentiment & Long-Term Safe Investment Plans - newser.com
Will Charles River Laboratories International Inc. stock maintain growth storyJuly 2025 Institutional & Free Weekly Chart Analysis and Trade Guides - newser.com
Can Charles River Laboratories International Inc. (RV6) stock withstand sector downturnsMarket Trend Review & Free Technical Confirmation Trade Alerts - newser.com
How strong is Charles River Laboratories International Inc. (RV6) stock earnings growth2025 Price Momentum & Weekly Hot Stock Watchlists - newser.com
How Charles River Laboratories International Inc. stock moves on employment dataQuarterly Portfolio Report & Stepwise Trade Signal Implementation - newser.com
Tools to monitor Charles River Laboratories International Inc. recovery probabilityIPO Watch & Reliable Intraday Trade Plans - newser.com
Will Charles River Laboratories International Inc. (RV6) stock announce special dividendJuly 2025 PreEarnings & Verified Momentum Stock Watchlist - newser.com
What To Expect From Charles River Laboratories’s (CRL) Q3 Earnings - FinancialContent
What earnings revisions data tells us about Charles River Laboratories International Inc.Earnings Beat & High Conviction Buy Zone Picks - newser.com
Charles River Laboratories International Inc. stock chart pattern explainedMarket Volume Report & Technical Analysis for Trade Confirmation - newser.com
Signal strength of Charles River Laboratories International Inc. stock in tech scannersQuarterly Investment Review & Daily Stock Trend Reports - newser.com
Why hedge funds are buying Charles River Laboratories International Inc. stockJobs Report & Free Accurate Trade Setup Notifications - newser.com
Nicholas Company Inc. Cuts Stock Holdings in Charles River Laboratories International, Inc. $CRL - MarketBeat
How Charles River Laboratories International Inc. (RV6) stock valuation compares with sector2025 Market Outlook & High Conviction Buy Zone Alerts - newser.com
Will Charles River Laboratories International Inc. stock benefit from green energy trendsTrend Reversal & Stepwise Trade Execution Plans - newser.com
What macro factors could drive Charles River Laboratories International Inc. (RV6) stock higherJuly 2025 Final Week & Verified Technical Signals - newser.com
Will Charles River Laboratories International Inc. stock benefit from commodity pricesTrade Entry Summary & Fast Gain Stock Trading Tips - newser.com
Sector ETF performance correlation with Charles River Laboratories International Inc.M&A Rumor & Fast Exit Strategy with Risk Control - newser.com
What does recent volatility data suggest for Charles River Laboratories International Inc.July 2025 Spike Watch & Reliable Price Action Trade Plans - newser.com
Applying chart zones and confluence areas to Charles River Laboratories International Inc.Market Sentiment Report & Consistent Income Trade Recommendations - newser.com
Cooke & Bieler LP Increases Stock Position in Charles River Laboratories International, Inc. $CRL - MarketBeat
Sumitomo Mitsui Trust Group Inc. Acquires 2,340 Shares of Charles River Laboratories International, Inc. $CRL - MarketBeat
Bessemer Group Inc. Cuts Stock Position in Charles River Laboratories International, Inc. $CRL - MarketBeat
Charles River Laboratories (CRL): Exploring Valuation After New Drug Discovery Collaborations Boost Innovation Prospects - simplywall.st
UNIVEST FINANCIAL Corp Trims Stake in Charles River Laboratories International, Inc. $CRL - MarketBeat
How Recent Moves Are Rewriting the Story for Charles River Laboratories - Yahoo Finance
AlphaQuest LLC Invests $368,000 in Charles River Laboratories International, Inc. $CRL - MarketBeat
What to Expect From Charles River Laboratories' Q3 2025 Earnings Report - MSN
Why Charles River Laboratories International Inc. (RV6) stock is upgraded to buyEarnings Overview Summary & Real-Time Market Sentiment Reports - newser.com
How to integrate Charles River Laboratories International Inc. into portfolio analysis tools - newser.com
Charles River Laboratories International Inc (CRL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.45%
6.29%
자본화:
|
볼륨(24시간):